You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
Turn on more accessible mode
Turn off more accessible mode
Skip Ribbon Commands
Skip to main content
Turn off Animations
Turn on Animations
Cancer Discovery Hub
It looks like your browser does not have JavaScript enabled. Please turn on JavaScript and try again.
Appointment
Find a Condition or Treatment
Find a Doctor
Menu
MAIN
Back to Home
About Us
Corporate Profile
Newsroom
Visitors Information
Contact Us
Patient Care
Specialties & Services
Your Clinic Visit
Cancer Information & Patient Support
E-Services
Find a Doctor
Research & Innovation
Research Labs
Programmes
Facilities
Our Researchers
Clinical Trials
SingHealth Research
Education & Training
Overview
Division of Cancer Education
Events
SingHealth Academy
Careers
Sponsorship
Scholarships
Giving
Why Give
Get Involved
Your Gift at Work
Be Informed
Make a Gift
Our Campaign
Volunteer
Research Labs
Back to Home
Cellular & Molecular Research
Molecular Carcinogenesis
Xenograft Platform for Drug Development
Molecular Mechanism and Targeted Therapy
Lymphoma Translational Research Laboratory
Molecular Oncology
Clinical Pharmacology Laboratory
Medical Sciences
Cancer Epigenome
Cancer Therapeutics Research
Cell Therapy and Cancer Vaccine
Precision Radiotherapeutics and Oncology Programme
Translational Research in Gastrointestinal Cancer
Genomic Medicine
Programme in Translational and Clinical Liver Research
Translational Cancer Biology
Laboratory of Applied Human Genetics
Blood Cancer and Stem Cell Lab
Breast Cancer Translational Research
Clinical Trials & Epidemiological Sciences
Clinical Trials Office
Biostatistics & Epidemiology Unit
NCCS Research Committee & Scientific Advisory Board
Research Divisions Organisation Chart
Programmes
Back to Home
Cancer Discovery Hub
STR-NCCS Satellite Tissue Bank
Joint Breast Cancer Registry
Data and Computational Science
Asia-Pacific Hepatocellular Carcinoma Trials Group
The VICTORY Consortium
ANCHOR
Facilities
Back to Home
Overview
Specialised Units
Shared Facilities
Shared Services
Research Contracts and Commercialisation
Our Researchers
Back to Home
Division of Medical Oncology
Division of Surgery & Surgical Oncology, SGH and NCCS
Division of Radiation Oncology
Division of Oncologic Imaging
Division of Supportive and Palliative Care
Cellular and Molecular Research
Division of Medical Sciences
Clinical Trials & Epidemiological Sciences
Research Reports
Clinical Trials
Back to Home
About Clinical Trials
Current Clinical Trials
ECRU
About Clinical Trials & Epidemiological Sciences
Clinical Trials Office
Biostatistics and Epidemiology Unit
SingHealth Research
Home
to skip to the main content on a page
to skip to the main content on a page
About Us
Back to Home
Corporate Profile
Vision & Mission
NCCS Leadership
Annual Report
Awards
Key Milestones
Whistle-blowing Policy
Newsroom
Press Releases
Check Fake News
Visitors Information
Contact Us
Feedback Form
Patient Liaison Service
Patient Care
Back to Home
Specialties & Services
Goh Cheng Liang Proton Therapy Centre
Haematology
Medical Oncology
Surgery & Surgical Oncology, SGH and NCCS
Radiation Oncology
Oncologic Imaging
Supportive & Palliative Care
Comprehensive Liver Cancer Clinic
Cancer Genetics Service
Lung Multidisciplinary Clinic
Nursing
NCCS Oncology @ SKH
NCCS Oncology Clinic @ CGH
Department of Psychosocial Oncology
Cancer Education and Information
Your Clinic Visit
Book an Appointment
When seeing a doctor
Pharmacy
Medicine
Charges & Payment
Financial Aid
Video Consultation
Rights & Responsibilities as a Patient
Cancer Information & Patient Support
For Patients
For Caregivers
Publications
Patient Stories
E-Services
Make/Change/Cancel Appointment
Request for Medical Report
Health Buddy App
Find a Doctor
Research & Innovation
Back to Home
Research Labs
Cellular & Molecular Research
Medical Sciences
Clinical Trials & Epidemiological Sciences
NCCS Research Committee & Scientific Advisory Board
Research Divisions Organisation Chart
Programmes
Cancer Discovery Hub
STR-NCCS Satellite Tissue Bank
Joint Breast Cancer Registry
Data and Computational Science
Asia-Pacific Hepatocellular Carcinoma Trials Group
The VICTORY Consortium
ANCHOR
Facilities
Overview
Specialised Units
Shared Facilities
Shared Services
Research Contracts and Commercialisation
Our Researchers
Division of Medical Oncology
Division of Surgery & Surgical Oncology, SGH and NCCS
Division of Radiation Oncology
Division of Oncologic Imaging
Division of Supportive and Palliative Care
Cellular and Molecular Research
Division of Medical Sciences
Clinical Trials & Epidemiological Sciences
Research Reports
Clinical Trials
About Clinical Trials
Current Clinical Trials
ECRU
About Clinical Trials & Epidemiological Sciences
Clinical Trials Office
Biostatistics and Epidemiology Unit
SingHealth Research
Education & Training
Back to Home
Overview
Division of Cancer Education
Undergraduate Education Unit
Postgraduate Education Unit
Nursing Education Unit
Faculty Development & Support Education Unit
Primary Care Oncology Education Unit
Communications, Mentoring, Ethics and Professionalism Education Unit
Medical Humanities Education Unit
Events
SingHealth Academy
Careers
Back to Home
Sponsorship
Career Conversion Programme
Scholarships
Giving
Back to Home
Why Give
About Us
Funding Innovative Research
Preventing Cancer
Advancing Medical Education
Helping Our Patients
Furthering Donor Impact
How Your Gift Helps
Get Involved
Honouring Your Gift
Become a Corporate Donor
Leave Your Legacy
Fundraise for Us
Join a Special Event
Your Gift at Work
Stories of Hope
Researchers in Action
Support for Patients
Our Work in the Community
Training Future Experts
Be Informed
Our Publications
Financial Statements
Make a Gift
Our Campaign
Make More Survivors
Jeans For Genes
Women VS Cancer
BCAM 2024
LCAM 2023
Volunteer
Home
>
Research & Innovation
>
Research Programmes
>
Cancer Discovery Hub
Cancer Discovery Hub
Facebook
WhatsApp
Email Us
share
Font Resize
A-
A
A+
Print
By:
Overview
Cancer Discovery Hub
STR-NCCS Satellite Tissue Bank
Data & Computational Science
Page Content
The Cancer Discovery Hub (CDH) is a one-stop pan-omics diagnostic and research core laboratory housed at the National Cancer Centre Singapore which specialises in state-of-the-art research-grade technologies and provide expert support and mentorship to investigators on all cancer related projects. CDH strives to be at the forefront of cutting-edge cancer research, enabling preclinical therapeutic development and supporting clinical trials for biomarker discovery. The research team supports several key cancer research programs in Singapore, including TETRAD (Targeted Therapy for Blood Cancer), SYMPHONY (Singapore lYMPHoma translatiONal study), STARLIGHT (Steering Translational Rare Cancer Research into the Light), and the KKH CBCC (KK Women's and Children's Hospital Children's Blood and Cancer Centre). The lab also supports the Singapore Translational Cancer Consortium (STCC), coordinating large-scale collaborative studies at the national level.
The CDH enables investigators to deeply interrogate the cancer genome, transcriptome, immunome, epigenome and metagenome using various technological platforms and technologies. These include the gene expression profiling using the NanoString nCounter, and next generation sequencing using the MGI G400 sequencer. Single-cell and spatial omic platforms are also available, including 10X Genomics (Chromium, Visium and CytAssist), Menarini Silicon Biosystem DEPArray and BGI Stereoseq. Importantly, the Visium and Stereoseq assays represent best-in-class technologies that are able to combine spatially-resolved whole transcriptome analysis with morphological context, complementing single cell gene expression information, enabling a complete view of disease complexity and accelerating novel biomarkers discovery.
To further translate bench research to pre-clinical and clinical studies, the CDH also developed a robust patient-derived xenograft (PDX), cell line (PDC), and organoid (PDO) facility providing a valuable resource for pre-clinical studies and testing. These models allow investigators to overcome issues faced with other types of in-vitro models, which often poorly recapitulate genetic and epigenetic heterogeneity of the actual tumour. Organoid models, in particular, enable faster generation of tumour models compared to xenograft models, while preserving the 3-dimensional nature of in vivo tumour physiology. This allows their rapid employment in personalised medicine protocols for therapeutic testing. Coupled with the molecular profiling platforms, this accelerates novel biomarker discovery for implementation in the clinic.
The Cancer Discovery Hub will continue to support key research programs nationally, and expand partnerships with key industry and academic partners, creating a culture of open collaboration, while simultaneously pushing the frontiers of translational cancer research.
Notable Achievements
Development of a cancer diagnostic assay with Asian-centric biomarkers
A study in collaboration between the National Cancer Centre Singapore (NCCS), A*STAR’s Diagnostics Development (DxD) Hub, Singapore General Hospital (SGH) and Lucence has led to the successful clinical and commercial deployment of the UNITED cancer diagnostic panel. This diagnostic panel is now available for clinical use in over 10 countries worldwide.
This work has been published by Ng CC, et al.
Front Mol Biosci
. 2022;9:963243 and cited in The Straits Times on Nov 22, 2022.
Selected presentations at major international cancer conferences
2024 EHA Congress, Madrid, Spain (Ms Lim Boon Yee)
2024 AACR Annual Meeting, San Diego (Ms Lee Jing Yi, Dr Ko Tun Kiat, Dr Jason Chan)
2023 CTOS Annual Meeting, Dublin, Ireland (Ms Elizabeth Lee)
2023 AACR Annual Meeting, Florida, USA (Ms Bavani Kannan)
2023 ESMO Sarcoma and Rare Cancers Congress, Lugano, Switzerland (Dr Jason Chan)
2022 ASH Annual Meeting, New Orleans, USA (Dr Jason Chan)
2022 CTOS Annual Meeting, Vancouver, Canada (Ms Lee Jing Yi)
2022 International Congress of the Asian Oncology Society, South Korea (Dr Ko Tun Kiat)
2022 AACR Annual Meeting, New Orleans, USA (Dr Jason Chan)
2022 JSMO Annual Meeting, Japan (Ms Elizabeth Lee)
Notable publications
Chan JY, Loh JW, Lim JQ, Liany H, Lee ECY, Lee JY, Kannan B, Lim BY, Guo Z, Lim K, Ha JCH, Ng CC, Ko TK, Huang D, Seow DYB, Cheng CL, Chan SH, Ngeow J, Teh BT, Lim ST, Ong CK. Single-cell landscape of idiopathic multicentric Castleman disease in identical twins. Blood. 2024 May 2;143(18):1837-1844.
Loh JW, Lee JY, Lim AH, Guan P, Lim BY, Kannan B, Lee ECY, Gu NX, Ko TK, Ng CC, Lim JCT, Yeong J, Lim JQ, Ong CK, Teh BT, Chan JY. Spatial transcriptomics reveal topological immune landscapes of Asian head and neck angiosarcoma. Commun Biol. 2023 Apr 27;6(1):461.
Lee JY, Kannan B, Lim BY, Li Z, Lim AH, Loh JW, Ko TK, Ng CC, Chan JY. The Multi-Dimensional Biomarker Landscape in Cancer Immunotherapy. Int J Mol Sci. 2022 Jul 16;23(14):7839.
Ng DYX, Li Z, Lee E, Kok JST, Lee JY, Koh J, Ng CC, Lim AH, Liu W, Ng SR, Lim KS, Huang XX, Hong JH, Guan P, Sim Y, Thike AA, Nasir NDM, Li S, Tan PH, Teh BT, Chan JY. Therapeutic and immunomodulatory potential of pazopanib in malignant phyllodes tumor. NPJ Breast Cancer. 2022 Apr 1;8(1):44.
Chan JY, Lim JQ, Yeong J, Ravi V, Guan P, Boot A, Tay TKY, Selvarajan S, Md Nasir ND, Loh JH, Ong CK, Huang D, Tan J, Li Z, Ng CC, Tan TT, Masuzawa M, Sung KW, Farid M, Quek RHH, Tan NC, Teo MCC, Rozen SG, Tan P, Futreal A, Teh BT, Soo KC. Multiomic analysis and immunoprofiling reveal distinct subtypes of human angiosarcoma. J Clin Invest. 2020 Nov 2;130(11):5833-5846.
1/28/2025 10:56 AM
×
SUBSCRIBE VIA EMAIL
Subscribe to our mailing list to get the updates to your email inbox...
Find a Doctor
Condition & Treatment
Home
Appointment
E-services